RELAY THERAPEUTICS
Live / Registered — Registered (as of 24 Nov 2020)
What this means for you
Registered since 24 Nov 2020. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88979360
- Registration number
- 6205848
- Mark type
- Design + words
- Filed
- 26 Oct 2018
- Published for opposition
- 24 Sept 2019
- Registered
- 24 Nov 2020
- Attorney of record
- Jessica L. Rothstein
Goods and services
- Class 042 — Scientific and technological services: Biochemical research and development services in the field of allosteric regulation; Research and development of pharmaceuticals; Research and development of technology in the field of pharmaceuticals; Development of pharmaceutical preparations and medicines; Drug development and discovery; Research and development of therapeutic drugs for the prevention or treatment of human diseases; Scientific research in the field of drug discovery and development for others; Biomedical research services; Scientific research; Preclinical development of therapeutic products
Owner
- Relay Therapeutics, Inc., Cambridge, MA, US
- Relay Therapeutics, Inc., Cambridge, MA, US
- Relay Therapeutics, Inc., Cambridge, MA, US
Prosecution history
- 24 Nov 2025 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 04 Jan 2023 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 04 Jan 2023 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 04 Jan 2023 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 04 Jan 2023 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 04 Jan 2023 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 24 Nov 2020 — REGISTERED-PRINCIPAL REGISTER
- 22 Oct 2020 — NOTICE OF DESIGN SEARCH CODE E-MAILED
- 21 Oct 2020 — 1(B) BASIS DELETED; PROCEED TO REGISTRATION
- 21 Apr 2020 — NOTICE OF ALLOWANCE CANCELLED
- 21 Oct 2020 — DIVISIONAL PROCESSING COMPLETE
- 21 Apr 2020 — DIVISIONAL REQUEST RECEIVED
- 21 Oct 2020 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 30 Apr 2020 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 21 Apr 2020 — TEAS REQUEST TO DIVIDE RECEIVED